Epstein Secrets

rill Lynch, Pierce, Fenner & Smith Incorporated The power of global connectionsTM From: Ens, Amanda Sent: Wednesday, August 24, 2016 3:30 PM To: 'Richard Kahn' Subject: RE: TEVA...IPR Decision Coming By Thurs...I like the Risk/Reward (+10% vs -5%) Rich, right after I sent this, the ruling came in earlier a

Jeffrey E." <[email protected]> To: Richard Kahn Subject: Re: Add to TEVA and AGN Date: Thu, 25 A

a Cons already assumes generic competition coming next year). Copaxone Litigation Timeline (from 2O Results Slidedeck) Scenario Analysis — BofAML Daniel Lundquist EFTA00820344 Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch The power of global connections"( Find all Conference Ev

rill Lynch, Pierce, Fenner & Smith Incorporated The power of global connections"' From: Ens, Amanda Sent: Wednesday, August 24, 2016 3:30 PM To: 'Richard Kahn' Subject: RE: TEVA...IPR Decision Coming By Thurs...I like the Risk/Reward (+10% vs -5%) Rich, right after I sent this, the ruling came in earlier a

"Jeffrey E." <[email protected]> To: Richard Kahn Subject: Re: Add to TEVA and AGN Date: Thu, 25 A

assumes generic competition coming next year). Copaxone Litigation Timeline (from 2Q Results Slidedeck) Scenario Analysis — BofAML EFTA00820353 Daniel Lundquist Healthcare Specialist Sales Global Equities The power of global connectionsTM Find all Conference Events via the Following Link: https://gems.ban

From: Richard Kahn < To: "jeffrey E." <[email protected]> Subject: Fwd: BMY Fails in 1L Lung (-17%)...MRK to Rally (+10%)...+ve Read-thru for AZN/Roche Date: Fri

From: Richard Kahn < To: "jeffrey E." <[email protected]> Subj

progression-free survival, as assessed by the Independent Radiology Review Committee, in patients with ≥ 5% PD-L1 tumor expression. EFTA00822174 Daniel Lundquist Healthcare Specialist Sales Global Equities The power of global connections TM' Disclaimer: This material was prepared by Sector Specialist Sale

pipeline, and long-term growth. Please find the report attached. Regards, Amanda From: Ens, Amanda Sent: Tuesday, August 02, 2016 3:00 PM To: 'Richard Kahn' Cc: 'Jeanne Brennan' Subject: RE: BAML HC...Thoughts on Positioning/Flows...Fear of Missing Biotech (FOMB)? - Buy the MLDIFOMB Basket EFTA00822652

From: Richard Kahn To: "jeffrey E." <[email protected]> Subject

or rebounding slightly off a three-year low, the first uptick since Feb but still indicating a 'Buy" 0. The indicators expected 12m return is +21%. Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States The power of global

From: Richard Kahn • To: "Jeffrey E." <[email protected]> Subj

From: Richard Kahn • To: "Jeffrey E." <[email protected]> Subject: Re: Add to TEVA and AGN Date: Thu, 25 Aug 2016 16:43:38 +0000 agreed her frequent recommendati

assumes generic competition coming next year). EFTA00665659 Copaxone Litigation Timeline (from 2Q Results Slidedeck) Scenario Analysis — BofAML Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States T: The power of glo

ore in =he write-up from yesterday on the Fear of Missing Biotech Basket —=MLDIFOMB. From: Ens, Amanda Sent: Monday, August 01, 2016 2:53 PM To: 'Richard Kahn' Cc: 'Jeanne Brennan' Subject: BAML HC...Thoughts on =ositioning/Flows...Fear of Missing Biotech (FOMB)? - Buy the MLDIFOMB =asket Please find =el

From: Richard Kahn Sent: Tuesday, August To: jeffrey E. Subject:

r rebounding slightly off a three-year low, the first =ptick since Feb but still indicating a "Buy" (). =he indicators expected 12m return is +21%. Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States The power of global

From: Richard Kahn Sent: Thursday, December 15, 2016 5:46 PM To: Jeffrey E. Subject: Fwd: US Healthcare Year Ahead...Buy ACAD, AGN, ANTM, CELG, CVS, DI-IR, EW, EV

Healthcare =ear Ahead...Buy ACAD, AGN, ANTM, CELG, CVS, DHR, EW, EVHC, RARE, REGN, =BA Date: =/b>December 15, 2016 at 10:59:39 =M EST To: =/b>"Rich Kahn' Reply-To: =/b>"Ens, Amanda" The =S team is out with their 2017 Year Ahead this morning (link) running through =LL sub-sectors with each analysts t

acies CVS/WBA given benefits from decelerating generic =rices (which will remain an overhang for Distributors). HHS appointment a =E2$4ve for HCIT. Daniel Lundquist 2 EFTA_R1_01916333 EFTA02665719 Healthcare Specialist =ales Global Equities Bank of America Merrill =ynch One Bryant Park I New York, 10036 I

From: Richard Kahn Sent: 12/15/2016 5:46:20 PM To: jeffrey E. [[email protected]] Subject: Fwd: US Healthcare Year Ahead...Buy ACAD, AGN, ANTM, CELG, CVS, DHR, EW,

From: Richard Kahn Sent: 12/15/2016 5:46:20 PM To: jeffrey E. [jeev

pharmacies CVS/WBA given benefits from decelerating generic prices (which will remain an overhang for Distributors). HHS appointment a —ve for HCIT. Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park | New York, 10036 | United States T: M: The power of gl